Exercise-associated hyponatremia effective at normalizing blood sodium levels than oral administration for asymptomatic EAH. Exercise-associated hyponatremia Exercise-associated hyponatremia, or EAH, is a fluid-electrolyte disorder caused by a decrease in sodium levels (hyponatremia) during or up to 24 hours after prolonged physical activity. This disorder can develop when marathon runners or endurance event athletes drink more fluid, usually water or sports drinks, than their kidneys can excrete. This excess water can severely dilute the level of sodium in the blood needed for organs, especially the brain, to function properly. The incidence of EAH in athletes has increased in recent years, especially in the
Hypotonic hyponatremia a side effect of certain medicines, lung problems such as pneumonia or abscess, brain disease, or certain cancers (most often small cell lung carcinoma). The cornerstone of therapy for SIADH is reduction of water intake. If hyponatremia persists, then demeclocycline (an antibiotic with the side effect of inhibiting ADH) can be used. SIADH can also be treated with specific antagonists of the ADH receptors, such as conivaptan or tolvaptan. Another cause is psychogenic polydipsia. A third group of people with hyponatremia are often said to be "hypervolemic". They are identified by the presence of peripheral edema. In fact, the term